| 发明名称 |
Pharmaceutical Formulations |
| 摘要 |
This invention relates to solid oral pharmaceutical formulations of (S)-methyl (1-((4-(3-(5-chloro-2-fluoro-3-(methylsulfonamido)phenyl)-1-isopropyl-1H-pyrazol-4-yl)pyrimidin-2-yl)amino)propan-2-yl)carbamate (COMPOUND A) and the use of the formulations for treating proliferative diseases, such as solid tumor diseases. |
| 申请公布号 |
US2014309250(A1) |
申请公布日期 |
2014.10.16 |
| 申请号 |
US201214359121 |
申请日期 |
2012.11.21 |
| 申请人 |
Novartis AG |
发明人 |
Verma Daya;Krishnamachan Yogita;Shen Xiaohong;Lee Hanchen;Li Ping;Singh Rajinder;Tan LayChoo |
| 分类号 |
A61K31/506 |
主分类号 |
A61K31/506 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A solid oral pharmaceutical formulation which comprises a solid dispersion comprising COMPOUND A. |
| 地址 |
Basel CH |
